Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.

about

Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections.Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye.

P2860

Q41382285-EC585730-3488-4A2E-BA7B-326C6A43F3C5 Q55110292-74B5D543-2EB5-421D-9849-EA930769C326

P2860

Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.

Item

http://www.wikidata.org/entity/Q36757415

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Effects of intravitreal ranibi ...... -related macular degeneration.

@ast

Effects of intravitreal ranibi ...... -related macular degeneration.

@en

type

Item

label

Effects of intravitreal ranibi ...... -related macular degeneration.

@ast

Effects of intravitreal ranibi ...... -related macular degeneration.

@en

prefLabel

Effects of intravitreal ranibi ...... -related macular degeneration.

@ast

Effects of intravitreal ranibi ...... -related macular degeneration.

@en

P1476

Effects of intravitreal ranibi ...... -related macular degeneration.

@en

P2093

Adam Kabiesz

http://www.w3.org/2001/XMLSchema#string

Malgorzata Nita

http://www.w3.org/2001/XMLSchema#string

Malgorzata W Kimsa

http://www.w3.org/2001/XMLSchema#string

Maria Formińska-Kapuścik

http://www.w3.org/2001/XMLSchema#string

Urszula Mazurek

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Current and emerging therapies for the treatment of age-related macular degeneration

Influence of ranibizumab treatment on the extracellular matrix in patients with neovascular age-related macular degeneration.

Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis

A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.

P304

357-365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CIA.S93820

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Strzalka-Mrozik

Katarzyna Michalska-Małecka

P577

2016-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299472967

http://www.w3.org/2001/XMLSchema#string

P698

27069359

http://www.w3.org/2001/XMLSchema#string

P932

4818053

http://www.w3.org/2001/XMLSchema#string

Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.

about

P2860

P2860

Effects of intravitreal ranibizumab on the untreated eye and systemic gene expression profile in age-related macular degeneration.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932